[go: up one dir, main page]

MX2017001738A - Vitamina b2 para la diabetes gestacional. - Google Patents

Vitamina b2 para la diabetes gestacional.

Info

Publication number
MX2017001738A
MX2017001738A MX2017001738A MX2017001738A MX2017001738A MX 2017001738 A MX2017001738 A MX 2017001738A MX 2017001738 A MX2017001738 A MX 2017001738A MX 2017001738 A MX2017001738 A MX 2017001738A MX 2017001738 A MX2017001738 A MX 2017001738A
Authority
MX
Mexico
Prior art keywords
vitamin
woman
gestational diabetes
relates
present
Prior art date
Application number
MX2017001738A
Other languages
English (en)
Other versions
MX384859B (es
Inventor
Mace Catherine
Malcolm Godfrey Keith
Silva Zolezzi Irma
Newton Baker Philip
Seng CHONG Yap
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2017001738A publication Critical patent/MX2017001738A/es
Publication of MX384859B publication Critical patent/MX384859B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
    • A23V2250/64—Sugar alcohols
    • A23V2250/641—Inositol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/70—Vitamins
    • A23V2250/704—Vitamin B
    • A23V2250/7044—Vitamin B2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Obesity (AREA)
  • Pediatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La presente invención se refiere a una composición de nutrición materna que comprende mioinositol y vitamina B2. Una composición tal se ha diseñado específicamente para proporcionar una nutrición óptima para una mujer que desee la gestación, una mujer gestante y/o para una mujer en período de lactancia. La presente invención se refiere, además, a la vitamina B2 para usar para tratar o prevenir la diabetes mellitus gestacional y una afección asociada con esta en un sujeto gestante o su descendencia, en donde la vitamina B2 se administra a dicho sujeto antes y/o durante la gestación y/o durante la lactancia.
MX2017001738A 2014-08-08 2015-08-06 Vitamina b2 y mio-inositol para para tratar y prevenir la diabetes gestacional. MX384859B (es)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP14180403 2014-08-08
EP14180396 2014-08-08
EP14180401 2014-08-08
EP15170915 2015-06-05
EP15170911 2015-06-05
PCT/EP2015/068190 WO2016020489A1 (en) 2014-08-08 2015-08-06 Vitamin b2 for gestational diabetes

Publications (2)

Publication Number Publication Date
MX2017001738A true MX2017001738A (es) 2017-08-10
MX384859B MX384859B (es) 2025-03-14

Family

ID=53836570

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017001738A MX384859B (es) 2014-08-08 2015-08-06 Vitamina b2 y mio-inositol para para tratar y prevenir la diabetes gestacional.
MX2021008858A MX2021008858A (es) 2014-08-08 2017-02-07 Vitamina b2 para la diabetes gestacional.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021008858A MX2021008858A (es) 2014-08-08 2017-02-07 Vitamina b2 para la diabetes gestacional.

Country Status (8)

Country Link
EP (3) EP4483890A3 (es)
CN (1) CN106573004B (es)
BR (1) BR112017002176B1 (es)
CA (1) CA2953286C (es)
ES (2) ES2802985T3 (es)
MX (2) MX384859B (es)
PH (1) PH12017500085B1 (es)
WO (1) WO2016020489A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE1650462A1 (en) * 2016-04-05 2017-10-06 Indevex Ab (Publ) A macronutrient composition for use in a method for treatment of gestational diabetes
KR20180049731A (ko) * 2016-11-03 2018-05-11 주식회사 쎌바이오텍 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
CN108872424A (zh) * 2018-04-16 2018-11-23 南京医科大学 十二烷酸和前列腺素e2组合作为巨大儿辅助诊断标志物及其应用
MY210247A (en) 2018-06-22 2025-09-04 Fonterra Cooperative Group Ltd Use of polar lipids to treat or prevent gestational diabetes mellitus
CN110101088A (zh) * 2019-05-09 2019-08-09 武汉正轩宇生物科技有限公司 用于妊娠糖尿病防治的精准营养代餐组合物及其使用方法
MX2022002063A (es) * 2019-08-26 2022-03-17 Nestle Sa Mioinositol y la prevencion de pprom.
CN115460934A (zh) * 2019-08-26 2022-12-09 雀巢产品有限公司 肌醇和早产的预防
US20220296534A1 (en) * 2019-08-30 2022-09-22 Societe Des Produits Nestle S.A. Scyllo-inositol and b-cell mediated disorders
EP4034092A1 (en) * 2019-09-24 2022-08-03 Société des Produits Nestlé S.A. Scyllo-inositol and its use as insulin sensitizer
WO2021259938A1 (en) * 2020-06-22 2021-12-30 Société des Produits Nestlé S.A. Compositions comprising myo-inositol and their use in the prevention of post partum haemorrhage (pph)
US10894812B1 (en) 2020-09-30 2021-01-19 Alpine Roads, Inc. Recombinant milk proteins
US10947552B1 (en) 2020-09-30 2021-03-16 Alpine Roads, Inc. Recombinant fusion proteins for producing milk proteins in plants
IL301396A (en) 2020-09-30 2023-05-01 Nobell Foods Inc Recombinant milk proteins and food compositions comprising the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001043571A1 (en) * 1999-12-14 2001-06-21 Scott Conrad Hohulin Dietary supplement system
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
WO2004032639A1 (en) * 2002-10-11 2004-04-22 Wyeth Nutritional formulations containing synbiotic substances
AU2004266043B2 (en) * 2003-08-21 2007-09-20 Duchesnay Inc. Micronutrient supplement
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
EP1932542A1 (en) * 2006-12-15 2008-06-18 TIMA Foundation Antioxidant composition and its use in diabetes
EP2011506A1 (en) * 2007-07-05 2009-01-07 Nestec S.A. Supplementation of maternal diet
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
US20140161878A1 (en) * 2012-12-12 2014-06-12 Sweet Wellness AB Multi-nutrient supplement and uses thereof
US20170087161A1 (en) * 2014-03-21 2017-03-30 Nestec S.A. Maternal vitamin b2 administration for the prevention of increased adiposity, overweight or obesity in the offspring

Also Published As

Publication number Publication date
CA2953286C (en) 2023-05-02
ES3003286T3 (en) 2025-03-10
EP3718418B1 (en) 2024-10-09
MX384859B (es) 2025-03-14
CN106573004A (zh) 2017-04-19
PH12017500085B1 (en) 2024-06-28
EP4483890A2 (en) 2025-01-01
BR112017002176A2 (pt) 2017-11-21
EP3177151B1 (en) 2020-04-22
CA2953286A1 (en) 2016-02-11
ES2802985T3 (es) 2021-01-22
EP3718418A1 (en) 2020-10-07
CN106573004B (zh) 2021-07-16
EP3177151A1 (en) 2017-06-14
WO2016020489A1 (en) 2016-02-11
PH12017500085A1 (en) 2017-05-22
MX2021008858A (es) 2021-08-11
BR112017002176B1 (pt) 2022-03-22
EP4483890A3 (en) 2025-03-05

Similar Documents

Publication Publication Date Title
MX2017001738A (es) Vitamina b2 para la diabetes gestacional.
MX2017001804A (es) Mioinositol y uno o mas probioticos y sus usos.
MX2021010033A (es) Composiciones microencapsuladas de cannabinoides.
GB201411467D0 (en) 7-hydroxy cannabidiol (7-oh-cbd) for use in the treatment of non-alcoholic fatty liver disease (nafld)
CL2013000594A1 (es) Composicion que comprende hidrolizado de proteina en base lactea que proviene del tratamiento de una solucion de un material proteinaceo de base lactea con al menos una endopeptidasa tipo tripsina, y una endopeptidasa tipo quimotripsina; uso de dicha composicion como fórmula infantil o complemento alimenticio para inducción de tolerancia oral en infantes o pacientes que lo necesitan, o para reducir el riesgo de alergias.
CL2016002732A1 (es) Suplementación microbioma neonatal
CL2015003343A1 (es) Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico.
AR086395A1 (es) Envase para el tratamiento de patologias
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
PH12017501695A1 (en) Treatment of type 2 diabetes mellitus patients
AR100028A1 (es) Composiciones nutricionales que contienen ácido estearidónico
MX2017004017A (es) Composicion nutricional que se usa para tratar o prevenir afecciones relacionadas con el embarazo.
MX2016011994A (es) Administracion de vitamina b2 materna para la prevencion del aumento de la adiposidad, el sobrepeso o la obesidad en la descendencia.
PH12016501553B1 (en) Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
Shifman et al. Intensive care and anaesthesia for blood loss in obstetrics. Clinical guidelines were approved by the Presidium of the Federation of Anaesthesiologists and Reanimatologists of Russia on 15/09/13 in Krasnoyarsk. Sectional commission in" Anesthesiology and Reanimatology" of the Ministry of Health of the Russian Federation approved the guidelines for submission to the Ministry of Health of the Russian Federation on 11/15/13
Fanos et al. Children of the Mother Goddess
Cavalla Status migrainosus and tension type headache: 3 case reports
Lenfestey Pseudoporphyria in an elderly patient: case report
CN302191919S (zh) 医用x射线乳腺摄影系统
CN302113031S (zh) 自动吸奶器主机(2203)
CN302536694S (zh) 病人用界面组件
UA92219U (ru) Лекарственное средство с метронидазолом для лечения дерматологических заболеваний
MX2018014140A (es) Composicion para usar en la profilaxis de enfermedades alergicas.
AR081794A4 (es) Pechera neonatal
AR095448A4 (es) Colchón para embarazadas